Triangle Securities Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$885K Sell
8,559
-333
-4% -$29.7K 0.18% 115
2026
Q1
$639K Sell
8,892
-632
-7% -$48.7K 0.14% 136
2025
Q4
$756K Sell
9,524
-131
-1% -$10.3K 0.16% 129
2025
Q3
$728K Sell
9,655
-143
-1% -$9.8K 0.16% 130
2025
Q2
$676K Sell
9,798
-65
-0.7% -$4.26K 0.17% 130
2025
Q1
$668K Sell
9,863
-197
-2% -$11.8K 0.17% 132
2024
Q4
$452K Sell
10,060
-4,268
-30% -$239K 0.12% 154
2024
Q3
$901K Sell
14,328
-9,887
-41% -$577K 0.23% 115
2024
Q2
$1.43M Sell
24,215
-891
-4% -$55.7K 0.4% 69
2024
Q1
$2M Sell
25,106
-139
-0.6% -$10.6K 0.57% 60
2023
Q4
$1.99M Sell
25,245
-192
-0.8% -$13.7K 0.62% 52
2023
Q3
$1.78M Sell
25,437
-377
-1% -$26.7K 0.63% 51
2023
Q2
$1.78M Buy
25,814
+199
+0.8% +$14.2K 0.61% 52
2023
Q1
$1.9M Sell
25,615
-391
-2% -$32.8K 0.68% 45
2022
Q4
$2.42M Sell
26,006
-555
-2% -$53.6K 0.89% 32
2022
Q3
$2.53M Sell
26,561
-388
-1% -$38.4K 1.04% 27
2022
Q2
$2.5M Sell
26,949
-1,008
-4% -$98.4K 0.97% 30
2022
Q1
$2.83M Sell
27,957
-2,656
-9% -$279K 0.95% 30
2021
Q4
$3.16M Sell
30,613
-174
-0.6% -$16.1K 0.99% 26
2021
Q3
$2.61M Buy
30,787
+144
+0.5% +$12.1K 0.89% 30
2021
Q2
$2.56M Buy
30,643
+99
+0.3% +$8.11K 0.86% 32
2021
Q1
$2.3M Buy
30,544
+2,424
+9% +$177K 0.83% 33
2020
Q4
$1.92M Buy
28,120
+798
+3% +$51.9K 0.76% 40
2020
Q3
$1.6M Buy
27,322
+560
+2% +$34.8K 0.72% 43
2020
Q2
$1.74M Sell
26,762
-547
-2% -$34.4K 0.83% 36
2020
Q1
$1.62M Buy
27,309
+825
+3% +$55.1K 0.93% 34
2019
Q4
$1.97M Buy
26,484
+53
+0.2% +$3.72K 0.85% 34
2019
Q3
$1.67M Buy
26,431
+363
+1% +$21.5K 0.82% 38
2019
Q2
$1.44M Buy
26,068
+245
+0.9% +$13.2K 0.73% 48
2019
Q1
$1.39M Sell
25,823
-83
-0.3% -$5.12K 0.73% 47
2018
Q4
$1.7M Buy
25,906
+1,105
+4% +$82.5K 1% 34
2018
Q3
$1.95M Buy
24,801
+152
+0.6% +$10.9K 1.04% 31
2018
Q2
$1.59M Sell
24,649
-3,405
-12% -$224K 0.89% 37
2018
Q1
$1.75M Sell
28,054
-40
-0.1% -$2.87K 1% 33
2017
Q4
$2.04M Buy
28,094
+383
+1% +$27.8K 1.16% 29
2017
Q3
$2.25M Sell
27,711
-497
-2% -$39.3K 1.34% 25
2017
Q2
$2.27M Buy
28,208
+895
+3% +$70.7K 1.5% 19
2017
Q1
$2.14M Buy
27,313
+370
+1% +$29.5K 1.37% 24
2016
Q4
$2.13M Buy
26,943
+453
+2% +$36.7K 1.42% 21
2016
Q3
$2.36M Sell
26,490
-590
-2% -$55.7K 1.63% 16
2016
Q2
$2.59M Sell
27,080
-5,462
-17% -$544K 1.93% 11
2016
Q1
$3.38M Sell
32,542
-2,710
-8% -$264K 2.2% 6
2015
Q4
$3.45M Sell
35,252
-833
-2% -$81.6K 2.31% 8
2015
Q3
$3.48M Sell
36,085
-2,358
-6% -$248K 2.63% 4
2015
Q2
$4.03M Sell
38,443
-2,500
-6% -$255K 2.85% 3
2015
Q1
$4.23M Sell
40,943
-2,905
-7% -$294K 2.93% 3
2014
Q4
$4.22M Buy
43,848
+1,650
+4% +$145K 3.01% 3
2014
Q3
$3.36M Sell
42,198
-225
-0.5% -$17.7K 2.58% 5
2014
Q2
$3.2M Sell
42,423
-5,337
-11% -$403K 2.45% 6
2014
Q1
$2.63M Buy
47,760
+4,872
+11% +$344K 2.36% 8
2013
Q4
$3.07M Sell
42,888
-1,122
-3% -$72.1K 2.49% 6
2013
Q3
$2.5M Sell
44,010
-3,076
-7% -$183K 2.18% 10
2013
Q2
$2.69M Buy
+47,086
New +$2.73M 1.99% 8

Other funds holding CVS

Triangle Securities Wealth Management's CVS Position: Q2 2026 in Review

Triangle Securities Wealth Management reduced its CVS Health (CVS) stake by 3.7% in Q2 2026, selling an estimated $29.7K and leaving 8,559 shares worth $885K. The position accounts for 0.18% of the portfolio, ranked #115.

Triangle Securities Wealth Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.23M in Q1 2015. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Triangle Securities Wealth Management held 8,559 shares of CVS Health worth $885K as of Q2 2026.
  • Triangle Securities Wealth Management sold 333 CVS Health shares in Q2 2026, an estimated $29.7K.
  • CVS Health made up 0.18% of Triangle Securities Wealth Management's portfolio in Q2 2026, its #115 holding.
  • Triangle Securities Wealth Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Triangle Securities Wealth Management's CVS Health position peaked at $4.23M in Q1 2015.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Triangle Securities Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.